Last 1,559 GBp
Change Today -4.50 / -0.29%
Volume 9.7M
GSK On Other Exchanges
Symbol
Exchange
OTC US
New York
Xetra
London
Mexico
Frankfurt
As of 11:35 AM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Andrew Philip Witty

Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee, GlaxoSmithKline plc
AgeTotal Calculated CompensationThis person is connected to 14 board members in 1 different organizations across 6 different industries.

See Board Relationships
487,207,000 GBP
As of Fiscal Year 2013

Background*

Sir Andrew Philip Witty has been the Chief Executive Officer at GlaxoSmithKline plc (GSK Plc) at GlaxoSmithKline Bangladesh Ltd. , GlaxoSmithKline Pakistan Ltd. and GlaxoSmithKline Biologicals S.A since May 21, 2008, and also serves as Member of its Corporate Executive Team. He served as Chief Executive Officer at GlaxoSmithKline Consumer Nigeria plc. Sir Witty served as the President of Pharmaceuticals Europe at GlaxoSmithKline PLC since January 2003 and also served ...

Read Full Background

Corporate Headquarters*

980 Great West Road
Brentford, Middlesex TW8 9GS

United Kingdom

Phone: 44 20 8047 5000
Fax: --

Board Members Memberships*

Former Director
Former Lead Non-Executive Board Member
2008-Present
Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee

Education*

BA
Nottingham University

Other Affiliations*

Annual Compensation*

Salary1,059,000 GBP
Bonus1,875,000 GBP
Total Annual Compensation2,934,000 GBP

Stock Options*

Restricted Stock Awards3,499,000 GBP
All Other Compensation774,000 GBP
Exercised Options Value1,180,963 GBP
Total Value of Options2,178,528 GBP

Total Compensation*

Total Annual Cash Compensation3,708,000 GBP
Total Short Term Compensation2,934,000 GBP
Other Long Term Compensation4,273,000 GBP
Total Calculated Compensation7,207,000 GBP
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GSK:LN 1,559.00 GBp -4.50

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
$1.6M
Marijn E. Dekkers Ph.D.Chairman of Management Board and Chief Executive Officer
Bayer AG
€2.9M
Lars Rebien Sørensen Chief Executive Officer and Member of the Senior Management Board
Novo Nordisk A/S
kr11.3M
Christopher A. Viehbacher Chief Executive Officer, Director and Member of Strategy Committee
Sanofi
€3.0M
Jean-Paul Agon Chairman, Chief Executive Officer and Chairman of Strategy & Sustainable Development Committee
L'Oreal SA
€3.9M
Compensation as of Fiscal Year 2013.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GLAXOSMITHKLINE PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.